UCSF 41st Annual Advances in Heart Disease 2024
Our 41st annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of weight loss drugs and heart health, heart failure, contemporary management of arrhythmias, critical care cardiology, mechanical circulatory support, erectile dysfunction and heart health, and pulmonary hypertension.
Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.
All sessions will be recorded and made available to participants for online viewing 30 days post course.
TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.
Objectives
- Providing the Best Management of Coronary Heart Disease, Hypertension, Lipid Disorders, Diabetes, Systolic and Diastolic Heart Failure, Atrial Fibrillation and Flutter, STEMI and Non-STEMI, Thromboembolic Disease;
- Refining Considerations for Atrial Fibrillation, Atrial Flutter, and Ventricular Tachycardia Ablation;
- Applying the Best Considerations of Percutaneous Interventions for Coronary Heart Disease;
- Improving the Use of Anti-Platelet and Anti-Coagulation Therapy for Cardiovascular Diseases;
- Recognizing Risk Stratification of Cardiovascular Disease;
- Optimizing the Management of Peripheral Artery Disease;
- Recognizing that Pathophysiology of Diseases and Treatment Options Differ among Racial and Ethnic Groups;
- Optimizing the Management of COVID-19 and its Cardiovascular Complications
_
Price : $80
